CYTH
Cyclo Therapeutics, Inc. Common Stock
CYTH
CYTH
Delisted
CYTH was delisted on the 25th of March, 2025.
22 hedge funds and large institutions have $2.84M invested in Cyclo Therapeutics, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 1 closing their positions.
Holders
22
Holders Change
–
Holders Change %
0%
% of All Funds
0.32%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
1
Increased
5
Reduced
6
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$567K |
2 |
2
Citadel Advisors
Miami,
Florida
|
$31.3K |
3 |
3
BlackRock
New York
|
$75.6K |
4 |
4
Geode Capital Management
Boston,
Massachusetts
|
$223K |
5 |
5
UBS Group
Zurich,
Switzerland
|
$15.3K |